NOTE:

Due to the current political context in Portugal and given the nature of the event, the public presentation of the SHARP Initiative results, originally scheduled for March 18 at the Portuguese Parliament, will be postponed.

We regret any inconvenience this change may cause, and a new date will be announced in due course, when we look forward to welcoming you.

--------------------------------------------------------------------------------------------------

Organized by the NOVA Center for Global Health (NCGH) from NOVA IMS, this event is part of a think tank initiative that has brought together experts from various healthcare fields to reflect on the future of CAR-T cell therapy in Portugal.

The objective is to present the results of the SHARP Initiative highlighting the potential of emerging health technologies and the role of cellular therapies. Additionally, key challenges and opportunities will be discussed, along with priority actions to ensure a balance between innovation and the sustainability of the National Health Service (SNS).

Disclaimer: The SHARP Think Tank Initiative is financially supported by Gilead Sciences.